These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 23186954

  • 1. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
    Gonzales MC, Lieb DC, Richardson DW, O'Brian JT, Aloi JA, Khardori RK.
    Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB.
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [Abstract] [Full Text] [Related]

  • 5. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y, Hori M, Taguchi M, Watanabe S, Fukumoto S.
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion.
    Sanda S, Schlingmann KP, Newfield RS.
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):385-91. PubMed ID: 18556971
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea.
    Kim MY, Tan AH, Ki CS, Lee JI, Jang HW, Shin HW, Kim SW, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    J Korean Med Sci; 2010 Feb; 25(2):317-20. PubMed ID: 20119591
    [Abstract] [Full Text] [Related]

  • 10. Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
    Roszko KL, Stapleton Smith LM, Sridhar AV, Roberts MS, Hartley IR, Gafni RI, Collins MT, Fox JC, Nemeth EF.
    J Bone Miner Res; 2022 Oct; 37(10):1926-1935. PubMed ID: 35879818
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
    Laurer E, Grünberger J, Naidoo U, Lanzersdorfer R, Wimleitner M, Tischlinger K, Högler W.
    Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
    [Abstract] [Full Text] [Related]

  • 15. [Calcium-sensing receptor and hypoparathyroidism].
    Michigami T.
    Clin Calcium; 2007 Aug; 17(8):1186-91. PubMed ID: 17660614
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review.
    Wu Y, Zhang C, Huang X, Cao L, Liu S, Zhong P.
    J Int Med Res; 2022 Jul; 50(7):3000605221110489. PubMed ID: 35818129
    [Abstract] [Full Text] [Related]

  • 18. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
    Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV.
    N Engl J Med; 1996 Oct 10; 335(15):1115-22. PubMed ID: 8813042
    [Abstract] [Full Text] [Related]

  • 19. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone.
    Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, Burkett L, Geffner ME.
    J Clin Endocrinol Metab; 2006 Jul 10; 91(7):2474-9. PubMed ID: 16608894
    [Abstract] [Full Text] [Related]

  • 20. Hypoparathyroidism.
    Al-Azem H, Khan AA.
    Best Pract Res Clin Endocrinol Metab; 2012 Aug 10; 26(4):517-22. PubMed ID: 22863393
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.